Mendra, Inc.

Mendra, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://mendra.com/

Last Round

Series A

Jan 22, 2026

Total Funding Raised

$164M

Momentum Score

25 /100

Company Overview

Mendra, Inc. is a biopharmaceutical company that acquires, develops, and commercializes therapies for rare diseases using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical AI, Drug Discovery

Business Model

B2B2C

Customer Profile

Government Contracts, Revenue Share

AI Layer

Application

Keywords

rare disease therapyorphan drugstechbioAI drug developmentdrug in-licensingbiopharmaceuticalAI clinical trialsdrug commercializationclinical trial enrollmentasset-centric biotechbiotech platformpatient identificationmedical AIultra-rare disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mendra, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mendra, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 22, 2026
Series AJan 21, 2026

Key People

Founding team and executive leadership

Lalarukh Haris Shaikh

Co-founder CTO

Founding Team

Mendra, Inc. Investors

Notable investors and investment history

InvestorRounds
OrbiMedSeries A
5AM VenturesSeries A
Lux CapitalSeries A
Wing Venture CapitalSeries A
8VCSeries A

Mendra, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mendra, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mendra, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year Founded2025
Last FundingJan 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.